MedTrace Logo

Mu Opioid Receptor 1 Expression and Activation Patterns in Colorectal Cancer

NCT04353882 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2020-05-19

No results posted yet for this study

Summary

Observational case-control study in a retrospective cohort of patients with stage II or III colorectal cancer undergoing scheduled surgery.

Conditions

  • Colorectal Surgery for Stage II / III Primary Colorectal Cancer

Interventions

OTHER

Assess the difference in MOR-1 expression between healthy and tumor tissue

Assess the difference in the quantitative expression of MOR-1 (by means of RT-qPCR) between healthy tissue and tumor tissue, in patients with stage II and III colorectal cancer undergoing scheduled surgery.

Sponsors & Collaborators

  • Hospital Universitario La Fe

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2021-06-01
Completion
2022-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04353882 on ClinicalTrials.gov